Frederic Resnic

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention
    Frederic S Resnic
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, Mass 02116, USA
    Am Heart J 145:42-6. 2003
  2. pmc Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty Registry
    Frederic S Resnic
    Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 57:904-11. 2011
  3. doi request reprint Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry
    Frederic S Resnic
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    JACC Cardiovasc Interv 5:82-9. 2012
  4. pmc Evaluation of an automated safety surveillance system using risk adjusted sequential probability ratio testing
    Michael E Matheny
    GRECC and Center for Health Services Research, Tennessee Valley Healthcare System, Veterans Administration, Nashville, TN, USA
    BMC Med Inform Decis Mak 11:75. 2011
  5. pmc Recurrent post-partum coronary artery dissection
    Taufiek K Rajab
    Division of Cardiac Surgery, Department of Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Cardiothorac Surg 5:78. 2010
  6. doi request reprint Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices
    Frederic S Resnic
    BrighamandWomen s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    JAMA 304:2019-27. 2010
  7. pmc The public health hazards of risk avoidance associated with public reporting of risk-adjusted outcomes in coronary intervention
    Frederic S Resnic
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Am Coll Cardiol 53:825-30. 2009
  8. doi request reprint Highlights from the 57th annual scientific session of the American College of Cardiology
    Frederic S Resnic
    Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02492, USA
    J Thorac Cardiovasc Surg 136:244-7. 2008
  9. ncbi request reprint Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention
    F S Resnic
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Am J Cardiol 88:5-9. 2001
  10. pmc A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention
    Frederic S Resnic
    Cardiovascular Division, Department of Radiology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 99:766-70. 2007

Research Grants

Detail Information

Publications33

  1. ncbi request reprint No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention
    Frederic S Resnic
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, Mass 02116, USA
    Am Heart J 145:42-6. 2003
    ..The objectives of this analysis were to evaluate the occurrence of no-reflow as an independent predictor of adverse events and to determine whether treatment with intracoronary vasodilator therapy affected clinical outcomes...
  2. pmc Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty Registry
    Frederic S Resnic
    Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 57:904-11. 2011
    ..This study investigated the impact of adding novel elements to models predicting in-hospital mortality after percutaneous coronary interventions (PCIs)...
  3. doi request reprint Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry
    Frederic S Resnic
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    JACC Cardiovasc Interv 5:82-9. 2012
    ..This study sought to quantify the learning curve for the safety and effectiveness of a newly introduced vascular closure device through evaluation of the NCDR (National Cardiovascular Data Registry) CathPCI clinical outcomes registry...
  4. pmc Evaluation of an automated safety surveillance system using risk adjusted sequential probability ratio testing
    Michael E Matheny
    GRECC and Center for Health Services Research, Tennessee Valley Healthcare System, Veterans Administration, Nashville, TN, USA
    BMC Med Inform Decis Mak 11:75. 2011
    ..We compared risk-adjusted sequential probability ratio testing (RA-SPRT) implemented in an automated tool to Massachusetts public reports of 30-day mortality after isolated coronary artery bypass graft surgery...
  5. pmc Recurrent post-partum coronary artery dissection
    Taufiek K Rajab
    Division of Cardiac Surgery, Department of Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Cardiothorac Surg 5:78. 2010
    ..The patient remained asymptomatic from a cardiac point of view...
  6. doi request reprint Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices
    Frederic S Resnic
    BrighamandWomen s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    JAMA 304:2019-27. 2010
    ..Automated surveillance of clinical registries may provide early warnings in the postmarket evaluation of medical device safety...
  7. pmc The public health hazards of risk avoidance associated with public reporting of risk-adjusted outcomes in coronary intervention
    Frederic S Resnic
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Am Coll Cardiol 53:825-30. 2009
    ....
  8. doi request reprint Highlights from the 57th annual scientific session of the American College of Cardiology
    Frederic S Resnic
    Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02492, USA
    J Thorac Cardiovasc Surg 136:244-7. 2008
  9. ncbi request reprint Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention
    F S Resnic
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Am J Cardiol 88:5-9. 2001
    ..Their discriminatory power is comparable to those of logistic models and neural network models. Accurate bedside risk stratification may be achieved with these simple models...
  10. pmc A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention
    Frederic S Resnic
    Cardiovascular Division, Department of Radiology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 99:766-70. 2007
    ..This cost savings was in addition to the previously demonstrated advantages of Angio-Seal in terms of patient comfort and preference...
  11. ncbi request reprint Special topics
    Frederic S Resnic
    Cardiovascular Fellowship Program, Yale University School of Medicine, New Haven, Connecticut, USA
    J Am Coll Cardiol 47:D41-4. 2006
  12. ncbi request reprint Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors
    F S Resnic
    Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02116, USA
    Am J Cardiol 88:493-6. 2001
    ..This benefit was most marked for patients receiving glycoprotein IIb-IIIa antagonists...
  13. ncbi request reprint Exploration of a bayesian updating methodology to monitor the safety of interventional cardiovascular procedures
    Frederic S Resnic
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Tower 3B, 75 Francis Street, Boston, MA 02115, USA
    Med Decis Making 24:399-407. 2004
    ....
  14. ncbi request reprint Transition from bare metal to drug eluting stenting in contemporary US practice: effect on incidence and predictors of clinically driven target lesion revascularization
    Michael Jonas
    Cardiovascular Division Cardiac Catheterization Laboratory, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Catheter Cardiovasc Interv 70:175-83. 2007
    ..The performance of drug eluting stents (DES) and impact on every day practice in the USA, where complex, nonselective cases are the rule, remain unknown...
  15. pmc Quantitative impact of cardiovascular risk factors and vascular closure devices on the femoral artery after repeat cardiac catheterization
    Klaus A Tiroch
    Department of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am Heart J 159:125-30. 2010
    ..We evaluated the exact quantitative long-term impact of repeated catheterizations, vascular closure devices, and cardiovascular risk factors on the femoral artery after cardiac catheterization...
  16. pmc Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts
    Laura Mauri
    MSc, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    Circulation 118:1817-27. 2008
    ..We sought to compare the clinical outcome of patients treated with DES with that of BMS...
  17. pmc Comparison of symptoms, treatment, and outcomes of coronary artery disease among rheumatoid arthritis and matched subjects undergoing percutaneous coronary intervention
    Sonali P Desai
    Division of Rheumatology, Immunology, and Allergy, Brigham and Women s Hospital, Boston, MA 02115, USA
    Semin Arthritis Rheum 40:215-21. 2010
    ..We investigated the presenting symptoms of CAD, coronary anatomy (single versus multi-vessel CAD), and treatment among a group of subjects undergoing percutaneous coronary intervention (PCI) with angioplasty and/or stenting...
  18. pmc Monitoring device safety in interventional cardiology
    Michael E Matheny
    Department of Radiology, Harvard Medical School, Boston, MA, USA
    J Am Med Inform Assoc 13:180-7. 2006
    ..S. Food and Drug Administration, but there are few systems to automate surveillance. Our objective was to develop a system to perform real-time monitoring of safety data using a variety of process control techniques...
  19. ncbi request reprint Risk-adjusted sequential probability ratio test control chart methods for monitoring operator and institutional mortality rates in interventional cardiology
    Michael E Matheny
    Decision Systems Group, Department of Radiology, Brigham and Women s Hospital, MA, USA
    Am Heart J 155:114-20. 2008
    ....
  20. ncbi request reprint Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients
    Nicholas Cox
    Cardiovascular Division Cardiac Catheterization Laboratory, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Am J Cardiol 94:1174-7. 2004
    ..quot; The use of transradial access and arterial access closure devices was associated with reduced vascular complications in the population of obese patients...
  21. pmc Vascular closure device failure: frequency and implications: a propensity-matched analysis
    Sripal Bangalore
    Division of Cardiology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Circ Cardiovasc Interv 2:549-56. 2009
    ..However, the frequency and consequence of failure of VCDs is not well defined...
  22. doi request reprint Guidelines for therapy of ST-segment-elevation acute myocardial infarction in patients presenting to Partners Healthcare system hospital emergency departments
    Andrew C Eisenhauer
    Interventional Cardiovascular Medicine Service, Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Crit Pathw Cardiol 7:11-20. 2008
    ..The result was not only the development of the following guidelines for therapy, but also an ongoing commitment to share patient-level data and outcomes for continuous quality assessment and improvement...
  23. pmc An algorithm for use of prasugrel (effient) in patients undergoing cardiac catheterization and percutaneous coronary intervention
    Julio Marchini
    Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Crit Pathw Cardiol 9:192-8. 2010
    ..Areas of focus include analysis of the benefit of prasugrel over clopidogrel in acute coronary syndrome patients and appropriate selection of patients for prasugrel treatment...
  24. pmc Effects of SVM parameter optimization on discrimination and calibration for post-procedural PCI mortality
    Michael E Matheny
    Decision Systems Group, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    J Biomed Inform 40:688-97. 2007
    ..The results were compared to those produced by logistic regression models optimized using the same indices. The choice of optimization parameters had a significant impact on performance in both SVM kernel types...
  25. pmc Validation of an automated safety surveillance system with prospective, randomized trial data
    Michael E Matheny
    Department of Radiology, Division of General Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Med Decis Making 29:247-56. 2009
    ..We sought to validate 3 methods for automated safety monitoring by evaluating clinical trials with elevated adverse events...
  26. ncbi request reprint A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices
    Nipun Arora
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Am Heart J 153:606-11. 2007
    ..The purpose of this study was to assess femoral arterial access-related vascular outcomes after invasive cardiology procedures with the routine use of VCDs...
  27. pmc Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention
    Venkatesan D Vidi
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 106:1234-40. 2010
    ....
  28. ncbi request reprint Efficacy and safety of the nitinol clip-based vascular closure device (Starclose) for closure of common femoral arterial cannulation at or near the bifurcation: a propensity score-adjusted analysis
    Sripal Bangalore
    New York University School of Medicine, New York, USA
    J Invasive Cardiol 23:194-9. 2011
    ..To evaluate the efficacy and safety of the nitinol clip-based closure device (Starclose®, Abbott Vascular, Santa Clara, California) in patients with femoral arterial cannulation at the common femoral artery bifurcation...
  29. doi request reprint Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention
    Klaus A Tiroch
    Brigham and Women s Hospital, Boston, MA, USA
    Am J Cardiol 102:1473-6. 2008
    ..VCD use was not independently associated with the development of RPH (p = 0.74). In conclusion, this large prospective cohort study identified CRI, but not VCD use, as an independent predictor for RPH and peripheral vascular disease...
  30. ncbi request reprint An analysis of door-to-balloon time in a single center to determine causes of delay and possibilities for improvement
    Eugene B Wu
    Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Catheter Cardiovasc Interv 71:152-7. 2008
    ..We analyzed door-to-balloon times in our institution to identify those factors which significantly prolong time to treatment in ST elevation myocardial infarction (STEMI)...
  31. ncbi request reprint A global goodness-of-fit test for receiver operating characteristic curve analysis via the bootstrap method
    Kelly H Zou
    Department of Radiology, Brigham and Women s Hospital, Harvard Medical School, MIT, MA, USA
    J Biomed Inform 38:395-403. 2005
    ..The main objective was to develop a global statistical hypothesis test for assessing the goodness-of-fit (GOF) for parametric ROC curves via the bootstrap...
  32. ncbi request reprint Effect of stent implantation on upstream coronary artery compliance--a cause of late plaque rupture?
    Michael R Ward
    Royal North Shore Hospital, Sydney, Australia
    Am J Cardiol 96:673-5. 2005
    ..01). We conclude that stenting causes an increase in vessel compliance immediately proximal to the stent, and that when a vessel has been previously stented, plaque rupture is most likely to occur at the stent inflow site...
  33. ncbi request reprint The case for outpatient coronary intervention: balancing charges and discharges
    Frederic S Resnic
    Circulation 115:2248-50. 2007

Research Grants7

  1. A System to Monitor Safety in Interventional Cardiology
    Frederic Resnic; Fiscal Year: 2005
    ..Once validated, the analytic software will be made publicly available. ..
  2. An Automated System to Monitor Medical Device Safety
    Frederic Resnic; Fiscal Year: 2007
    ..This approach can be readily extended to monitor the safety of technologies outside of interventional cardiology as outcomes data repositories become available. ..
  3. An Automated System to Monitor Medical Device Safety
    Frederic Resnic; Fiscal Year: 2009
    ..This approach can be readily extended to monitor the safety of technologies outside of interventional cardiology as outcomes data repositories become available. ..